Medical / Drug Development
'Pepaxst' Emerges as New Multiple Myeloma Treatment
Professor Byun Sung-kyu from the Department of Hematology at Seoul St. Mary's Hospital explains the new treatment option 'Pepaxst' for patients with relapsed/refractory multiple myeloma. Provided by SC Bio SC Bio, a biotechnology company, has launched a humanitarian drug cost support program for 'Pe
2025.10.29